Replies to post #522073 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

if NVCR is as good as you claimed, then tell me why BMS terminated the trial with NVCR.

It was Bayer Health, not BMS that terminated the trial.

Likely because NVCR announced they are working with MRK/Keytruda instead of Opdivo. Combos between NVCR and MRK underway or planned:

. The "2 The Top" P2 in nGBM with early results in
. The Keynote D58 planned registration trial in nGBM
..The iKeynote B36 early study in NSCLC